Abbott Laboratories (ABT)
NYSE · Healthcare
Abbott Laboratories Shareholder Equity 2007–2025
Abbott Laboratories annual shareholder equity history from 2007 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Abbott Laboratories shareholder equity as of December 31, 2025: 52.13B, a 9.37% increase year-over-year.
- Abbott Laboratories shareholder equity for 2025 were 52.13B, a 9.37% increase from 2024.
- Abbott Laboratories shareholder equity for 2024 were 47.66B, a 23.47% increase from 2023.
- Abbott Laboratories shareholder equity for 2023 were 38.60B, a 5.23% increase from 2022.
- Abbott Laboratories shareholder equity for 2022 were 36.69B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Abbott Laboratories Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $52,130 |
| 2024 | $47,664 |
| 2023 | $38,603 |
| 2022 | $36,686 |
| 2021 | $35,802 |
| 2020 | $32,784 |
| 2019 | $31,088 |
| 2018 | $30,524 |
| 2017 | $30,897 |
| 2016 | $20,538 |
| 2015 | $21,211 |
| 2014 | $21,526 |
| 2013 | $25,171 |
| 2012 | $26,721 |
| 2011 | $24,440 |
Abbott Laboratories Shareholder Equity — FAQ
Abbott Laboratories (ABT) shareholder equity over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ABT's shareholder equity history?
The chart and table above show Abbott Laboratories's shareholder equity by year and by quarter, including the growth rate.